Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.045 CAD | -10.00% | -18.18% | -35.71% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 13.63M 18.63M |
---|---|---|---|---|---|
Net income 2021 | -6M -8.2M | Net income 2022 | -5M -6.83M | EV / Sales 2021 | - |
Net Debt 2021 | 1.26M 1.73M | Net Debt 2022 | 3.99M 5.45M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.46
x | P/E ratio 2022 |
-2.41
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.85% |
Latest transcript on Hemostemix Inc.
1 day | -10.00% | ||
1 week | -18.18% | ||
Current month | -30.77% | ||
1 month | -30.77% | ||
3 months | -40.00% | ||
6 months | -55.00% | ||
Current year | -35.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Christina Wu
DFI | Director of Finance/CFO | - | 20-03-04 |
Peter Pavlin
COO | Chief Operating Officer | - | 22-05-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Lacey
CHM | Chairman | 67 | 20-03-10 |
Ronnie Hershmann
BRD | Director/Board Member | - | 20-02-08 |
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.045 | -10.00% | 82,500 |
24-04-22 | 0.05 | 0.00% | 20,000 |
24-04-19 | 0.05 | 0.00% | 111,000 |
24-04-18 | 0.05 | -9.09% | 16,000 |
24-04-17 | 0.055 | 0.00% | 4,200 |
Delayed Quote Toronto S.E., April 24, 2024 at 11:55 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.71% | 2.86M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.78% | 22.2B | |
-16.53% | 21.23B | |
-9.10% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- HEM Stock